Vivus Inc Quick Ratio (VVUS) starting from the first quarter 2020 to first quarter 2019, Financial Strength Trends, Rankings, Financial Ratios - CSIMarket
CSIMarket Company Name, Ticker, Customers, else..
 


• Quick Ratio
• Working Capital
• LT Debt to Equity
• Debt to Equity
• Leverage Ratio
• Tangible Leverage
• Interest Coverage
• Debt Coverage
• Work. Cap. Per Revenue
Vivus Inc  (VVUS)

Vivus Inc's Quick Ratio

VVUS's quarterly Quick Ratio and Cash & cash equivalent, Current Liabilities growth


In the wake of the increase in Current Liabilities in the first quarter 2020, Quick Ratio fell to 0.14 a new company low.

Within Major Pharmaceutical Preparations industry 356 other companies have achieved higher Quick Ratio than Vivus Inc in first quarter 2020. While Quick Ratio total ranking in the first quarter 2020 has deteriorated compared to the prior quarter from 3803 to 3834.

Explain Quick Ratio?
How much Cash & cash equivalents VVUS´s has?
What are VVUS´s Current Liabilities?



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

VVUS Quick Ratio (Mar 31 2020)
Q1		 (Dec 31 2019)
Q4		 (Sep 30 2019)
Q3		 (Jun 30 2019)
Q2		 (Mar 31 2019)
Q1
Y / Y Current Liabilities Change 495.35 % 421.17 % 487.75 % 580.79 % 33.83 %
Y / Y Cash & cash equivalent Change -68.61 % -70.65 % -65.15 % -23.62 % -49.96 %
Quick Ratio MRQ 0.14 0.15 0.18 0.42 2.74
VVUS's Total Ranking # 3834 # 3803 # 3790 # 1316 # 156
Seq. Current Liabilities Change 1.17 % -0.67 % 0.53 % 489.33 % -11.43 %
Seq. Cash & cash equivalent Change 0.63 % -18.61 % -57.49 % -9.83 % -5.93 %



Quick Ratio first quarter 2020 Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 357
Healthcare Sector # 831
Overall Market # 3834


Quick Ratio Statistics
High Average Low
28 6.13 0.14
(Mar 31 2012)   (Mar 31 2020)




Financial Statements
Vivus Inc's Current Liabilities $ 228 Millions Visit VVUS's Balance sheet
Vivus Inc's Cash & cash equivalent $ 33 Millions Visit VVUS's Balance sheet
Source of VVUS's Sales Visit VVUS's Sales by Geography


Cumulative Vivus Inc's Quick Ratio

VVUS's Quick Ratio for the trailling 12 Months

VVUS Quick Ratio

 (Mar 31 2020)
12 Months		 (Dec 31 2019)
12 Months		 (Sep 30 2019)
12 Months		 (Jun 30 2019)
12 Months		 (Mar 31 2019)
12 Months
Y / Y Current Liabilities TTM Growth 490.99 % 398.73 % 283.77 % 154.13 % -0.47 %
Y / Y Cash & cash equivalent TTM Growth -56.01 % -51.38 % -48.02 % -46.49 % -50.75 %
Quick Ratio TTM 0.22 0.38 0.66 1.23 2.97
Total Ranking TTM # 5126 # 2620 # 5051 # 717 # 4721
Seq. Current Liabilities TTM Growth 26.49 % 34.1 % 54.44 % 125.61 % 6.74 %
Seq. Cash & cash equivalent TTM Growth -26.42 % -22.43 % -17.63 % -6.42 % -18.69 %

Quick ratio ranking by company, industry and sector >> Back to VVUS Financial Strength Comparisons >> Go to Compare VVUS Quick Ratio to its Competitors

On the trailing twelve months basis Due to rise in Current Liabilities in the Q1 2020 to $227.79 millions, cumulative Quick Ratio decreased to 0.22 below the Vivus Inc average Quick Ratio.
Quick Ratio is the average cumulative value over the last four quarters.

Among companies operating within Major Pharmaceutical Preparations industry 490 other companies have achieved higher Quick Ratio than Vivus Inc. While Quick Ratio total ranking has deteriorated compared to the previous twelve months ending in the fourth quarter 2019 from 2620 to 5126.

Explain Quick Ratio?
How much Cash & cash equivalents VVUS´s has?
What are VVUS´s Current Liabilities?

TTM Quick Ratio Company Ranking
Within: No.
Within the Major Pharmaceutical Preparations Industry # 491
Healthcare Sector # 959
Within the Market # 5126


trailing twelve months Quick Ratio Statistics
High Average Low
6.23 4.14 0.22
(June 30. 2014)   (Mar 31 2020)




Companies with similar Quick Ratio in the quarter ending Mar 31 2020, within Major Pharmaceutical Preparations Industry Quick RatioMar 31 2020 MRQ Cash & cash equivalentMar 31 2020 MRQ Current Liabilities
Bausch Health Companies Inc   0.39 $ 912.000  Millions$ 2,341.000  Millions
Vaccinex Inc   0.38 $ 2.491  Millions$ 6.620  Millions
Allergan plc  0.35 $ 2,618.300  Millions$ 7,433.400  Millions
Abbott Laboratories  0.34 $ 3,668.000  Millions$ 10,808.000  Millions
Immunoprecise Antibodies Ltd   0.34 $ 1.934  Millions$ 5.701  Millions
Avalo Therapeutics Inc   0.33 $ 5.724  Millions$ 17.330  Millions
Gridai Technologies Corp  0.32 $ 1.671  Millions$ 5.143  Millions
Merck and Co Inc   0.32 $ 7,432.000  Millions$ 23,483.000  Millions
Elite Pharmaceuticals Inc   0.32 $ 1.207  Millions$ 3.826  Millions
Pfizer Inc  0.31 $ 10,350.000  Millions$ 33,890.000  Millions
Avricore Health Inc   0.26 $ 0.237  Millions$ 0.905  Millions
Ani Pharmaceuticals Inc  0.26 $ 20.414  Millions$ 79.356  Millions
Nrx Pharmaceuticals Inc   0.26 $ 0.081  Millions$ 0.316  Millions
Vtv Therapeutics Inc   0.24 $ 2.906  Millions$ 11.970  Millions
Eli Lilly And Company  0.22 $ 1,777.400  Millions$ 7,906.300  Millions
Health right Discoveries Inc   0.22 $ 2.067  Millions$ 9.362  Millions
Medicure Inc   0.22 $ 2.080  Millions$ 9.430  Millions
Reshape Lifesciences Inc  0.21 $ 2.117  Millions$ 10.295  Millions
Q Biomed inc   0.18 $ 0.741  Millions$ 4.109  Millions
Cytodyn inc   0.18 $ 7.057  Millions$ 39.955  Millions
9 Meters Biopharma Inc   0.17 $ 2.743  Millions$ 15.836  Millions
International Stem Cell Corporation  0.17 $ 0.708  Millions$ 4.205  Millions
Timber Pharmaceuticals Inc   0.17 $ 0.300  Millions$ 1.816  Millions
American Bio Medica Corporation  0.16 $ 0.581  Millions$ 3.648  Millions
Zyla Life Sciences  0.16 $ 14.541  Millions$ 93.041  Millions
The Greater Cannabis Company Inc   0.15 $ 0.295  Millions$ 1.909  Millions
Teva Pharmaceutical Industries Limited  0.15 $ 1,804.000  Millions$ 12,322.000  Millions
Opko Health Inc   0.15 $ 34.530  Millions$ 235.982  Millions
Vivus Inc  0.14 $ 32.854  Millions$ 227.786  Millions
Novartis Ag  0.14 $ 4,767.000  Millions$ 33,059.000  Millions

Date modified: 2026-09-02T20:16:03+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.